Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity.
Herzog
Melanie
M
Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Storch
Caroline Henrike
CH
Gut
Philipp
P
Kotlyar
Dimitry
D
Füllekrug
Joachim
J
Ehehalt
Robert
R
Haefeli
Walter Emil
WE
Weiss
Johanna
J